Literature DB >> 22983831

Ectopic acromegaly due to growth hormone releasing hormone.

Ali A Ghazi1, Alireza Amirbaigloo, Azizollah Abbasi Dezfooli, Navid Saadat, Siavash Ghazi, Marina Pourafkari, Farrokh Tirgari, Dheepti Dhall, Serguei Bannykh, Shlomo Melmed, Odelia Cooper.   

Abstract

Acromegaly secondary to extra-pituitary tumors secreting growth hormone releasing hormone (GHRH) is rarely encountered. We review the literature on ectopic acromegaly and present the index report of ectopic acromegaly secondary to GHRH secretion from a mediastinal paraganglioma. Clinical and pathological manifestations and therapeutic management of 99 patients with ectopic acromegaly are reviewed. Acromegaly secondary to ectopic GHRH secretion is usually caused by a neuroendocrine tumor in the lung and pancreas. We report an additional cause of ectopic acromegaly from a mediastinal paraganglioma. Diagnostic criteria of ectopic GHRH syndrome include biochemical and pathologic tumoral confirmation of GHRH secretion and expression. Management of ectopic acromegaly consists of surgical resection of the primary tumor and biochemical normalization, with possible adjuvant use of somatostatin analogs. The review demonstrates that there are several tumor types, including paragangliomas which may secrete GHRH, leading to acromegaly. Clinical and laboratory manifestations of the syndrome and challenges in diagnosis and management of these rarely encountered patients require early diagnosis and appropriate treatment to prevent long-term morbidity and mortality with ectopic acromegaly.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22983831      PMCID: PMC3553305          DOI: 10.1007/s12020-012-9790-0

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  101 in total

1.  Acromegaly caused by ectopic growth hormone-releasing hormone production from a bronchial carcinoid tumor.

Authors:  T Gudbjartsson; B A Agnarsson; P S Palsson; A Johannesson
Journal:  Thorac Cardiovasc Surg       Date:  2011-04-08       Impact factor: 1.827

Review 2.  Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.

Authors:  Monica Gola; Mauro Doga; Stefania Bonadonna; Gherardo Mazziotti; Pier Paolo Vescovi; Andrea Giustina
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

3.  A consensus on criteria for cure of acromegaly.

Authors:  A Giustina; P Chanson; M D Bronstein; A Klibanski; S Lamberts; F F Casanueva; P Trainer; E Ghigo; K Ho; S Melmed
Journal:  J Clin Endocrinol Metab       Date:  2010-04-21       Impact factor: 5.958

4.  Ectopic acromegaly due to a pancreatic neuroendocrine tumor producing growth hormone-releasing hormone.

Authors:  Danielle E Weiss; Hannes Vogel; M Beatriz S Lopes; Steven D Chang; Laurence Katznelson
Journal:  Endocr Pract       Date:  2011 Jan-Feb       Impact factor: 3.443

5.  The approach to the patient with paraganglioma.

Authors:  Hartmut P H Neumann; Charis Eng
Journal:  J Clin Endocrinol Metab       Date:  2009-08       Impact factor: 5.958

6.  Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentaloma.

Authors:  E Verrua; C L Ronchi; E Ferrante; D I Ferrari; S Bergamaschi; S Ferrero; M C Zatelli; V Branca; A Spada; P Beck-Peccoz; A G Lania
Journal:  Pituitary       Date:  2010-09       Impact factor: 4.107

7.  111In-octreotide is superior to 123I-metaiodobenzylguanidine for scintigraphic detection of head and neck paragangliomas.

Authors:  Klaas Pieter Koopmans; Pieter L Jager; Ido P Kema; Michiel N Kerstens; Frans Albers; Robin P F Dullaart
Journal:  J Nucl Med       Date:  2008-07-16       Impact factor: 10.057

8.  Effects of somatostatin analogs on a growth hormone-releasing hormone secreting bronchial carcinoid, in vivo and in vitro studies.

Authors:  M van Hoek; L J Hofland; Y B de Rijke; F H van Nederveen; R R de Krijger; P M van Koetsveld; S W J Lamberts; A J van der Lely; W W de Herder; R A Feelders
Journal:  J Clin Endocrinol Metab       Date:  2008-11-18       Impact factor: 5.958

9.  Mediastinal paragangliomas: the mayo clinic experience.

Authors:  Morgan L Brown; Gilberto E Zayas; Martin D Abel; William F Young; Hartzell V Schaff
Journal:  Ann Thorac Surg       Date:  2008-09       Impact factor: 4.330

10.  Ectopic growth hormone-releasing hormone secretion by a neuroendocrine tumor causing acromegaly: long-term follow-up results.

Authors:  Neşe Colak Ozbey; Yersu Kapran; Alp Bozbora; Yeşim Erbil; Cemil Tascioglu; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

View more
  17 in total

Review 1.  Acromegaly Caused by Ectopic Growth Hormone Releasing Hormone Secretion: A Review.

Authors:  Iga Zendran; Gabriela Gut; Marcin Kałużny; Katarzyna Zawadzka; Marek Bolanowski
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

2.  ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.

Authors:  M Falconi; B Eriksson; G Kaltsas; D K Bartsch; J Capdevila; M Caplin; B Kos-Kudla; D Kwekkeboom; G Rindi; G Klöppel; N Reed; R Kianmanesh; R T Jensen
Journal:  Neuroendocrinology       Date:  2016-01-05       Impact factor: 4.914

3.  'Open-and-close' pituitary surgery in an acromegalic man presenting with excessive sweatiness.

Authors:  Kitty Kit Ting Cheung; Francis Chun Chung Chow; Anthony Wing Ip Lo
Journal:  BMJ Case Rep       Date:  2016-06-09

Review 4.  Ectopic acromegaly due to a GH-secreting pituitary adenoma in the sphenoid sinus: a case report and review of the literature.

Authors:  Claudia Ramírez; Laura-Cristina Hernández-Ramirez; Ana-Laura Espinosa-de-los-Monteros; Juan Manuel Franco; Gerardo Guinto; Moises Mercado
Journal:  BMC Res Notes       Date:  2013-10-12

5.  pNET co-secreting GHRH and calcitonin: ex vivo hormonal studies in human pituitary cells.

Authors:  Taiba Zornitzki; Hadara Rubinfeld; Lyudmila Lysyy; Tal Schiller; Véronique Raverot; Ilan Shimon; Hilla Knobler
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2016-02-05

Review 6.  Growth Hormone-Releasing Hormone in Diabetes.

Authors:  Leonid E Fridlyand; Natalia A Tamarina; Andrew V Schally; Louis H Philipson
Journal:  Front Endocrinol (Lausanne)       Date:  2016-10-10       Impact factor: 5.555

7.  Metastatic Pancreatic Neuroendocrine Tumor that Progressed to Ectopic Adrenocorticotropic Hormone (ACTH) Syndrome with Growth Hormone-releasing Hormone (GHRH) Production.

Authors:  Rie Tadokoro; Shotaro Sato; Fumiko Otsuka; Makoto Ueno; Shinichi Ohkawa; Hideki Katakami; Matsuo Taniyama; Shoichiro Nagasaka
Journal:  Intern Med       Date:  2016-10-15       Impact factor: 1.271

8.  Acromegaly with empty sella syndrome.

Authors:  Reyna Daya; Faheem Seedat; Khushica Purbhoo; Saajidah Bulbulia; Zaheer Bayat
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2021-07-01

9.  Phaeochromocytoma and Acromegaly: a unifying diagnosis.

Authors:  C Mumby; J R E Davis; J Trouillas; C E Higham
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2014-05-01

10.  GHRH secretion from a pancreatic neuroendocrine tumor causing gigantism in a patient with MEN1.

Authors:  Vinaya Srirangam Nadhamuni; Donato Iacovazzo; Jane Evanson; Anju Sahdev; Jacqueline Trouillas; Lorraine McAndrew; Tom R Kurzawinski; David Bryant; Khalid Hussain; Satya Bhattacharya; Márta Korbonits
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.